Thursday, November 21, 2024 11/21/2024

Administrative Supplement: Development of functional magnetic resonance imaging-guided adaptive radiotherapy for head and neck cancer patients using novel MR-Linac device

Award Number: R01DE028290
ORGANIZATION: NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Group Awards By:

View Award Abstract

PROJECT SUMMARY/ABSTRACT: Delivering dose to cancers while sparing normal tissue is the ultimate goal in radiotherapy (RT) treatment, especially in the head and neck. By identifying tumors which are more likely to respond early in treatment, as well as subvolumes of resistant tumor, RT plans could be changed each day to take advantage of biological alteration in the tumor, resulting in reduced side effects with equivalent probability of cure. Functional imaging techniques have demonstrated utility in clinical series in discriminating early responders to radiation therapy in head and neck cancer (HNC), as well as identifying radiation resistant disease post-therapy. These functional imaging techniques could be utilized to actively adapt radiation therapy with high frequency during the radiation treatment course. In tandem with our industrial partner (Elekta Medical Systems), our group has recently been awarded an NIH R01 grant (5R01DE028290-03, FREEDOMM-RT) to develop the hardware, software, technical, and quality assurance infrastructure for functional image-guided RT for HNC patients. The resulting high-frequency anatomical and functional imaging data derived from this project, in addition to additional MRI data sources from our institution forms a corpus of unprecedented novel “big data” for MRI-guided adaptive RT. Therefore, in this supplement, we propose the selective curation, annotation, and dissemination of these data to facilitate community-driven artificial intelligence (AI) model building efforts in order to more readily translate MR-guided RT technologies into the clinic. The proposed one-year supplement is composed of data curation and data challenge execution efforts. Specifically, we will curate high-quality anatomical and functional MRI sequences at multiple timepoints and generate corresponding segmentations regions of interest; dosimetric, demographic, and clinical data will be curated for each patient. These benchmark datasets will be anonymized and transmitted to The Cancer Imaging Archive for public re-use, thereby fostering the research community to develop robust RT-centric AI projects. Additionally, to facilitate community engagement with our novel benchmark datasets, we will initiate a series of AI “data challenges”. Through these challenges we will directly foster novel AI innovation to solve clinically relevant RT problems. Successful completion of this project will enable a modernized and integrated biomedical data ecosystem for public use of RT data for AI model building. Moreover, the proposed benchmark datasets will provide a foundation to achieve the long-term goal of personalized medicine for HNC patients using AI to reduce oro-dental sequelae while maintaining excellent cure rates, directly complementing the goals of the parent grant. Finally, this supplement will positively impact patients by enabling the characterization of malignancy for improved therapeutic intervention and downstream translational application of AI technologies.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2024 ( Subtotal = $0 )
2024	2022	THE UNIVERISTY OF TEXAS MD ANDERSON CANCER CENTER, A COMPONENT OF THE UNIVERISTY OF TEXAS SYSTEM	1515 HOLCOMBE BLVD	HOUSTON	TX	77030	HARRIS	USA	Dietary Supplement Research Program	000	4	2/28/2024	SUPPLEMENT FOR EXPANSION	$0
														Subtotal = $0

Issue Date FY: 2023 ( Subtotal = $832,719 )
2023	2023	UNIVERSITY OF TEXAS M. D. ANDERSON CANCER CENTER, THE	1515 HOLCOMBE BLVD	HOUSTON	TX	77030	HARRIS	USA	Oral Diseases and Disorders Research	002	5	5/9/2023	SUPPLEMENT FOR EXPANSION	$204,847
2023	2023	UNIVERSITY OF TEXAS M. D. ANDERSON CANCER CENTER, THE	1515 HOLCOMBE BLVD	HOUSTON	TX	77030	HARRIS	USA	Oral Diseases and Disorders Research	001	5	5/8/2023	NON-COMPETING CONTINUATION	$627,872
2023	2022	UNIVERSITY OF TEXAS M. D. ANDERSON CANCER CENTER, THE	1515 HOLCOMBE BLVD	HOUSTON	TX	77030	HARRIS	USA	Oral Diseases and Disorders Research	000	4	4/25/2023	NON-COMPETING CONTINUATION	$0
														Subtotal = $832,719

Issue Date FY: 2022 ( Subtotal = $1,181,876 )
2022	2022	UNIVERSITY OF TEXAS M. D. ANDERSON CANCER CENTER, THE	1515 HOLCOMBE BLVD	HOUSTON	TX	77030	HARRIS	USA	Dietary Supplement Research Program	002	4	8/4/2022	SUPPLEMENT FOR EXPANSION	$322,681
2022	2022	UNIVERSITY OF TEXAS M. D. ANDERSON CANCER CENTER, THE	1515 HOLCOMBE BLVD	HOUSTON	TX	77030	HARRIS	USA	Oral Diseases and Disorders Research	000	4	5/16/2022	NON-COMPETING CONTINUATION	$635,635
2022	2022	UNIVERSITY OF TEXAS M. D. ANDERSON CANCER CENTER, THE	1515 HOLCOMBE BLVD	HOUSTON	TX	77030	HARRIS	USA	Oral Diseases and Disorders Research	001	4	5/18/2022	SUPPLEMENT FOR EXPANSION	$223,560
														Subtotal = $1,181,876

Issue Date FY: 2021 ( Subtotal = $885,719 )
2021	2021	UNIVERSITY OF TEXAS M D ANDERSON CANCER CENTER	1515 HOLCOMBE BLVD UNIT 207	HOUSTON	TX	77030	HARRIS	USA	Oral Diseases and Disorders Research	001	2	4/16/2021	SUPPLEMENT FOR EXPANSION	$18,713
2021	2021	UNIVERSITY OF TEXAS M D ANDERSON CANCER CENTER	1515 HOLCOMBE BLVD UNIT 207	HOUSTON	TX	77030	HARRIS	USA	Oral Diseases and Disorders Research	002	3	5/10/2021	NON-COMPETING CONTINUATION	$867,006
2021	2020	UNIVERSITY OF TEXAS M D ANDERSON CANCER CENTER	1515 HOLCOMBE BLVD UNIT 207	HOUSTON	TX	77030	HARRIS	USA	Oral Diseases and Disorders Research	000	2	11/3/2020	NON-COMPETING CONTINUATION	$0
														Subtotal = $885,719

Issue Date FY: 2020 ( Subtotal = $729,474 )
2020	2020	UNIVERSITY OF TEXAS M D ANDERSON CANCER CENTER	1515 HOLCOMBE BLVD UNIT 207	HOUSTON	TX	77030	HARRIS	USA	Oral Diseases and Disorders Research	001	2	6/12/2020	NON-COMPETING CONTINUATION	$697,777
2020	2020	UNIVERSITY OF TEXAS M D ANDERSON CANCER CENTER	1515 HOLCOMBE BLVD UNIT 207	HOUSTON	TX	77030	HARRIS	USA	Oral Diseases and Disorders Research	000	1	12/14/2019	SUPPLEMENT FOR EXPANSION	$31,697
														Subtotal = $729,474

Issue Date FY: 2019 ( Subtotal = $688,539 )
2019	2019	UNIVERSITY OF TEXAS M D ANDERSON CANCER CENTER	1515 HOLCOMBE BLVD UNIT 207	HOUSTON	TX	77030	HARRIS	USA	Oral Diseases and Disorders Research	000	1	8/12/2019	NEW	$688,539
														Subtotal = $688,539

Grand Total All Awards = $4,318,327

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Administrative Supplement: Development of functional magnetic resonance imaging-guided adaptive radiotherapy for head and neck cancer patients using novel MR-Linac device

Award Number: R01DE028290

ORGANIZATION: NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer